Clinical trials
Pancreatic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
123 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 11 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 15 |
| 2025 | 14 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Recruiting | 30 |
| Active, not recruiting | 21 |
| Terminated | 14 |
| Unknown status | 7 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 9 |
| Pfizer | 7 |
| AstraZeneca | 5 |
| Celgene | 4 |
| Hoffmann-La Roche | 4 |
| Novartis Pharmaceuticals | 4 |
| Australasian Gastro-Intestinal Trials Group | 3 |
| Bristol-Myers Squibb | 3 |
| Panbela Therapeutics, Inc. | 3 |
| Verastem, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 123 |
| Colorectal Neoplasms | 34 |
| Ovarian Neoplasms | 32 |
| Carcinoma, Non-Small-Cell Lung | 31 |
| Breast Neoplasms | 25 |
| Neoplasm Metastasis | 22 |
| Neoplasms | 20 |
| Stomach Neoplasms | 20 |
| Prostatic Neoplasms | 19 |
| Urinary Bladder Neoplasms | 18 |
Trials
Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.
23 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.